Viewing Study NCT03322657


Ignite Creation Date: 2025-12-24 @ 6:50 PM
Ignite Modification Date: 2026-02-04 @ 9:59 AM
Study NCT ID: NCT03322657
Status: COMPLETED
Last Update Posted: 2021-11-16
First Post: 2017-10-13
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Sugammadex Versus Neostigmine for Reversal of Rocuronium Neuromuscular
Sponsor: The Cleveland Clinic
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Neuromuscular Blockade View
None Anesthesia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Sugammadex View
None Neostigmine View
None Reversal of neuromuscular block View